Period:
Draw Mode:
| Volume | 17,383 |
|
|||||
| News | - | ||||||
| Day High | 0.722 | Low High |
|||||
| Day Low | 0.6702 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Avenue Therapeutics Inc | ATXI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.02 | 2.94% | 0.70 | 13:07:24 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.6958 | 0.6702 | 0.722 | 0.68 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 102 | 17,383 | $ 0.6904829 | $ 12,003 | - | 0.539 - 16.65 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:13:07 | 5 | $ 0.69 | USD |
Avenue Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 5.73M | 8.18M | - | 0 | -3.55M | -0.43 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Avenue Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATXI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.7798 | 0.7798 | 0.539 | 0.6507386 | 149,630 | -0.0798 | -10.23% |
| 1 Month | 0.8536 | 0.8569 | 0.539 | 0.7231194 | 81,676 | -0.1536 | -17.99% |
| 3 Months | 1.13 | 1.25 | 0.539 | 0.9497478 | 73,002 | -0.43 | -38.05% |
| 6 Months | 1.07 | 1.36 | 0.539 | 1.07 | 155,455 | -0.37 | -34.58% |
| 1 Year | 5.77 | 16.65 | 0.539 | 4.84 | 1,397,717 | -5.07 | -87.87% |
| 3 Years | 165.60 | 170.10 | 0.539 | 12.76 | 1,235,959 | -164.90 | -99.58% |
| 5 Years | 43.50 | 188.40 | 0.539 | 15.34 | 760,139 | -42.80 | -98.39% |
Avenue Therapeutics Description
| Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain. |